Leishmaniasis control in the light of the COVID-19 pandemic in Africa

Leishmaniasis is a parasitic disease, endemic to Africa, Asia, and South America due to inadequate access to medication and underreporting of leishmaniasis cases. Leishmaniasis has two forms: cutaneous and visceral. The fight against leishmaniasis has been greatly affected by the coronavirus disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Uwishema, Olivier, Sapkota, Suhail, Wellington, Jack, Onyeaka, Chinyere Vivian Patrick, Onyeaka, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339101/
https://www.ncbi.nlm.nih.gov/pubmed/35936565
http://dx.doi.org/10.1016/j.amsu.2022.104263
_version_ 1784760105072328704
author Uwishema, Olivier
Sapkota, Suhail
Wellington, Jack
Onyeaka, Chinyere Vivian Patrick
Onyeaka, Helen
author_facet Uwishema, Olivier
Sapkota, Suhail
Wellington, Jack
Onyeaka, Chinyere Vivian Patrick
Onyeaka, Helen
author_sort Uwishema, Olivier
collection PubMed
description Leishmaniasis is a parasitic disease, endemic to Africa, Asia, and South America due to inadequate access to medication and underreporting of leishmaniasis cases. Leishmaniasis has two forms: cutaneous and visceral. The fight against leishmaniasis has been greatly affected by the coronavirus disease 2019 (COVID-19) pandemic that impacted resource distribution and access to medication. Continuous effort in vaccine development and affordable therapeutics are necessary to eliminate leishmaniasis in low-income countries. Further research is necessary to determine molecular drug resistance markers in leishmaniasis patients. In this analysis, we focus on the effect of COVID-19 on leishmaniasis in Africa.
format Online
Article
Text
id pubmed-9339101
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93391012022-08-01 Leishmaniasis control in the light of the COVID-19 pandemic in Africa Uwishema, Olivier Sapkota, Suhail Wellington, Jack Onyeaka, Chinyere Vivian Patrick Onyeaka, Helen Ann Med Surg (Lond) Short Communication Leishmaniasis is a parasitic disease, endemic to Africa, Asia, and South America due to inadequate access to medication and underreporting of leishmaniasis cases. Leishmaniasis has two forms: cutaneous and visceral. The fight against leishmaniasis has been greatly affected by the coronavirus disease 2019 (COVID-19) pandemic that impacted resource distribution and access to medication. Continuous effort in vaccine development and affordable therapeutics are necessary to eliminate leishmaniasis in low-income countries. Further research is necessary to determine molecular drug resistance markers in leishmaniasis patients. In this analysis, we focus on the effect of COVID-19 on leishmaniasis in Africa. Elsevier 2022-07-31 /pmc/articles/PMC9339101/ /pubmed/35936565 http://dx.doi.org/10.1016/j.amsu.2022.104263 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Uwishema, Olivier
Sapkota, Suhail
Wellington, Jack
Onyeaka, Chinyere Vivian Patrick
Onyeaka, Helen
Leishmaniasis control in the light of the COVID-19 pandemic in Africa
title Leishmaniasis control in the light of the COVID-19 pandemic in Africa
title_full Leishmaniasis control in the light of the COVID-19 pandemic in Africa
title_fullStr Leishmaniasis control in the light of the COVID-19 pandemic in Africa
title_full_unstemmed Leishmaniasis control in the light of the COVID-19 pandemic in Africa
title_short Leishmaniasis control in the light of the COVID-19 pandemic in Africa
title_sort leishmaniasis control in the light of the covid-19 pandemic in africa
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339101/
https://www.ncbi.nlm.nih.gov/pubmed/35936565
http://dx.doi.org/10.1016/j.amsu.2022.104263
work_keys_str_mv AT uwishemaolivier leishmaniasiscontrolinthelightofthecovid19pandemicinafrica
AT sapkotasuhail leishmaniasiscontrolinthelightofthecovid19pandemicinafrica
AT wellingtonjack leishmaniasiscontrolinthelightofthecovid19pandemicinafrica
AT onyeakachinyerevivianpatrick leishmaniasiscontrolinthelightofthecovid19pandemicinafrica
AT onyeakahelen leishmaniasiscontrolinthelightofthecovid19pandemicinafrica

Ejemplares similares